3Asahara T,Murohara T,Sullivan A,et al.Isolation of putative progenitor endothelial cells for angiogenesis.Science,1997,275:964-967.
4Rehman J,Li J,Orschell CM,et al.Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors.Circulation,2003,107:1164-1169.
5Kocher AA,Schuster MD,Szabolcs MJ,et al.Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis,reduces remodeling and improves cardiac function.Nat Med,2001,7:430-436.
7Yin AH,Miraglia S,Zanjani ED,et al.Expression of population of functional endothelial precursors.Blood,2002,95:952-958.
8Peichev M,Naiyer AJ,Pereira D,et al.Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors.Blood,2000,95:952-958.
9Shintani S,Murohara T,Ikeda H,et al.Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.Cirulation,2001,103:2776-2779.
10Eizawa T,Ikeda U,Murakami Y,et al.Increase in circulating endothelial progenitor cells after aortic aneurysm repair.Heart Vessels,2004,19:107-110.
2Setoguchi M, Leri A, Wang S, et al. Activation of cyclins and cyclin-dependent kinases, DNA synthesis, and myocyte mitotic division in pacing-induced heart failure in dogs. Lab Invest, 1999,79 : 1545-1558.
3Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature.2002.415:240-243.
4Beltrami AP, Urbanek K, Kajstum J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engt J Med,2001,344 : 1750-1757.
5Piero Anversa, Jan Kajstura. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Rea,1998,83:1-14.
6Kajstura J, Left A, Finato N, et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A, 1998,95:8801-8805.
7Reiss K, Cheng W, Pierzchalski P, et al. Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle. Exp Cell Res,1997,235:198-209.
8Reiss K, Cheng W, Giordano A, et al.Myocardial infarction is coupled with the activation of Cyelins and Cyclin-Dependent Kinases in Myocytes. Exp Cell Res,1996,225:44-54.
9Kajstura J, Pertoldi B, Leri A, et al. Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol, 2000,156:813-819.
10Teyssier-Le Discorde M, Prost S, Nandrot E, et al. Spatial and temporal mapping of c-kit and its ligand, stem cell factor expression during human embryonic haemopoiesis. Br J Haematol, 1999,107:247-253.
1Fadini G P, de Kreutzenberg S, Albiero M, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vase Biol, 2008, 28, 997-1004.
2Li X, Xu B. HMG-CoA Reductase Inhibitor Regulates Endothelial Progenitor Function Through the Phosphatidylinositol 3' Kinase/AKT Signal Transduction Pathway. Appl Bioehem Bioteehnol, 2008 Jun 18. [Epub ahead of print]
3Yao E H, Fukuda N, Matsumoto T, et al. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res, 2007, 30: 1119-1128.
4Westenbrink B D, Lipsic E, van der Meer P, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J, 2007, 8: 2018- 2027.
5Werner C, Kamani C H, Gensch C, et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes, 2007, 56: 2609-2615.
6Nissen S E, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med, 2007, 356~ 2457-2471.
7Gensch C, Clever Y P, Werner C, et al. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis, 2007, 192: 67-74.
8Redondo S, Hristov M, Gumbel D, et al. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1. Thromb Haemost, 2007, 97: 979-987.
9Forst T, Karagiannis E, Lubben G, et aI. Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis, 2008, 197: 311-317.
10Gizard F, Bruemmer D. Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator- Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases. PPAR Res, 2008, 2008 : 429123.
